Sarepta Therapeutics Says FDA Lifts Clinical Hold On SRP-5051 To Treat Duchenne Muscular Dystrophy

Quest Diagnostics Says FDA Grants Breakthrough Designation For Adeno-associated Virus Test

Quest Diagnostics (DGX), a diagnostic information services provider, announced Wednesday that its AAVrh74 ELISA assay (CDx) has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).

RTTNews | 498 dagar sedan

FDA OKs Elevidys As First Gene Therapy To Treat Duchenne Muscular Dystrophy

Sarepta Therapeutics, Inc. announced Friday that the U.S. Food and Drug Administration or FDA has accelerated approval of ELEVIDYS (delandistrogene moxeparvovec-rokl) for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene.

RTTNews | 566 dagar sedan

Sarepta Therapeutics Updates Of BLA For Sarepta's Duchenne Muscular Dystrophy Drug Candidate

Sarepta Therapeutics, Inc. (SRPT) on Wednesday provided the following update on the Biologics License Application (BLA) for SRP-9001 (delandistrogene moxeparvovec), which is currently under review for the treatment of ambulant individuals with Duchenne muscular dystrophy (DMD) who have a confirmed mutation of the DMD gene.

RTTNews | 596 dagar sedan

Sarepta Submits BLA For SRP-9001 To Treat Ambulant Patients With Duchenne Muscular Dystrophy

Genetic medicine maker Sarepta Therapeutics, Inc. (SRPT) announced Thursday that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the accelerated approval of SRP-9001 (delandistrogene moxeparvovec) to treat ambulant patients with Duchenne muscular dystrophy.

RTTNews | 833 dagar sedan

European Shares Set For Muted Start Before US Jobs Data

European stocks may drift lower at open on Friday as investors brace for the all-important U.S. jobs report later in the day.

RTTNews | 5h 50minuter sedan

Sensex, Nifty Follow Global Peers Lower; IT Stocks Surge

Indian shares opened lower on Friday, mirroring weak cues from global markets amid Trump's tariff threats and expectations of fewer interest-rate cuts by the U.S. Federal Reserve in 2025.

RTTNews | 7h 4minuter sedan

Asian Markets Mixed Amid Cautious Trades

Asian stock markets are trading mixed on Friday, following the mixed cues from European markets and lack of cues from Wall Street overnight as they were closed, as traders are cautious ahead of the release of the closely watched US monthly jobs later in the day, which will potentially provide additional clarity about the strength of the labor market and the outlook for interest rate cuts.

RTTNews | 8h 8minuter sedan

Australian Market Maintains Early Losses In Mid-market

The Australian stock market is maintain its early losses in mid-market trading on Friday, also adding to the losses in the previous session, following the mixed cues from European markets and lack of cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling well below the 8,300 level, with weakness in financial, energy and technology stocks partially offset by gains in mining stocks.

RTTNews | 8h 43minuter sedan

EURUSD	1.0286	GBPUSD	1.22776	AUDUSD	0.61909
USDJPY	158.375	USDCAD	1.44175	USDCHF	0.91293